Literature DB >> 28478486

Treatment of spondylodiscitis after rectopexy: surgery is always required.

J-L Faucheron1,2, B Trilling3,4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28478486     DOI： 10.1007/s10151-017-1606-z

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  6 in total

Review 1.  Focus on abdominal rectopexy for full-thickness rectal prolapse: meta-analysis of literature.

Authors:  F Cadeddu; P Sileri; M Grande; E De Luca; L Franceschilli; G Milito
Journal:  Tech Coloproctol       Date:  2011-12-15       Impact factor: 3.781

2.  Laparoscopic ventral rectopexy is the gold standard treatment for rectal prolapse.

Authors:  F Reche; J-L Faucheron
Journal:  Tech Coloproctol       Date:  2015-09-08       Impact factor: 3.781

3.  Laparoscopic anterior rectopexy to the promontory for full-thickness rectal prolapse in 175 consecutive patients: short- and long-term follow-up.

Authors:  Jean-Luc Faucheron; David Voirin; Romain Riboud; Pierre-Alexandre Waroquet; Jerome Noel
Journal:  Dis Colon Rectum       Date:  2012-06       Impact factor: 4.585

4.  Spondylodiscitis after rectopexy: diagnostic of a rare complication.

Authors:  A Pasquer; F Djeudji; A Pechoux; X Barth
Journal:  Tech Coloproctol       Date:  2016-12-07       Impact factor: 3.781

5.  Mesh erosion after laparoscopic rectopexy: a benign complication?

Authors:  B Trilling; G Martin; J-L Faucheron
Journal:  Colorectal Dis       Date:  2014-10       Impact factor: 3.788

Review 6.  Anterior rectopexy for full-thickness rectal prolapse: Technical and functional results.

Authors:  Jean-Luc Faucheron; Bertrand Trilling; Edouard Girard; Pierre-Yves Sage; Sandrine Barbois; Fabian Reche
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742
  6 in total
  1 in total

1.  Treatment of spondylodiscitis after rectopexy: surgery is always required-Fauheron JL, Trilling B.

Authors:  A Pasquer
Journal:  Tech Coloproctol       Date:  2017-05-15       Impact factor: 3.781
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.